Summary
This memorandum explores the reimbursement and regulatory landscape for telemedicine services, particularly those relating to population health. The memo provides a brief definition of telemedicine, in contrast to broader telehealth services (sec. II), before outlining how government and private payers reimburse providers for certain telemedicine services (sec. III). Additionally, the memo identifies alternative sources of telemedicine funding via grant and demonstration projects (sec. V). Finally, the memorandum examines major policy issues that may impact telemedicine (sec. VI).